Kimberly-Clark makes and sells personal care and hygiene products under well-known consumer brands. The core product portfolio spans baby and child care (Huggies, Pull-Ups), adult incontinence (Depend, Poise), feminine care (Kotex), family care tissue products (Kleenex, Cottonelle, Scott), and professional hygiene products (WypAll). Kimberly-Clark sells consumer products through mass merchandisers, supermarkets, drugstores, and e-commerce, with Walmart representing approximately 16% of net sales. The business is organized into two segments: North America, which is the core higher-margin business, and International Personal Care, covering markets including China, Brazil, South Korea, and Indonesia. Kimberly-Clark is contributing its international tissue and professional business to a joint venture with Suzano, retaining a 49% stake, to focus on higher-growth personal care. Revenue is driven by volume, product mix, and pricing. The company targets premium product mix expansion — North America's diaper business has shifted from roughly 40% premium mix a decade ago to nearly 70% today — while also offering value-tier products to retain price-sensitive consumers. Kimberly-Clark also targets roughly 5–6% of cost of goods sold annually in productivity savings to fund brand investment and support margins. Key input costs include pulp, superabsorbent materials, and polypropylene. In late 2025, Kimberly-Clark announced an agreement to acquire Kenvue, the consumer health spinoff from Johnson & Johnson, with the deal expected to close in the second half of 2026.